NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,075 | -61.1% | 500 | 0.0% | 0.01% | -58.8% |
| Q2 2023 | $20,750 | -31.0% | 500 | 0.0% | 0.02% | -34.6% |
| Q1 2023 | $30,070 | -18.0% | 500 | 0.0% | 0.03% | -16.1% |
| Q4 2022 | $36,675 | -3.5% | 500 | 0.0% | 0.03% | -6.1% |
| Q3 2022 | $38,000 | +8.6% | 500 | 0.0% | 0.03% | +22.2% |
| Q2 2022 | $35,000 | -14.6% | 500 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $41,000 | +7.9% | 500 | 0.0% | 0.03% | +17.4% |
| Q4 2021 | $38,000 | -67.2% | 500 | -50.0% | 0.02% | -65.7% |
| Q3 2021 | $116,000 | -47.7% | 1,000 | 0.0% | 0.07% | -75.5% |
| Q2 2021 | $222,000 | – | 1,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |